Mbx Biosciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Mbx Biosciences Inc's ROI in the second quarter of 2026?
Mbx Biosciences Inc recorded a cumulative net loss of $-104 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -25.94%.

Within the Healthcare sector 300 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2048 to 3393.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	63.39 %	67.63 %	99.16 %	213.14 %	1129.8 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	412	438	370	388	220
Return On Investment (TTM)	-25.94 %	-24.47 %	-28.68 %	-29.25 %	-31.3 %
MBX's Overall Ranking	# 3393	# 2048	# 3103	# 2818	# 2456
Seq. Investment Change TTM	13.6 %	16.71 %	10.19 %	11.84 %	16.55 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-104	-87	-87	-80	-77

MBX Company Profile >> Back to MBX Roi Comparisons >> See Annual MBX Return On Investment

Return On Investment MBX's Ranking
Within:	No.
Industry	# 113
Sector	# 301
Overall	# 3393

Return On Investment Statistics
High	Average	Low
-24.47 %	-30.23 %	-40.67 %
(Mar 31 2026)		(Dec 31 2024)

Financial Statements
Mbx Biosciences Inc's II. Quarter Investments	$ 412 Millions	MBX's Balance sheet
Mbx Biosciences Inc's II. Quarter Income	$ -37 Millions	Quarterly MBX's Income Statement
MBX's Income by Division		See MBX's Income by Division

MBX Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024
Total Investments in Millions	370	257	0	0	0
Y / Y Investment Growth	43.56 %	-	-	-	-
Net Income in Millions	-87	-62	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-23.53 %	-24.05 %	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MBX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MBX's Competitors
Subscribers only: Roi for Mbx Biosciences Inc's Suppliers
Subscribers only: Return On Investment for MBX's Customers

Other Ratios
MBX's Roa	MBX's Inventory Turnover Ratio	MBX's Growth Rates	MBX's Dividend Statistics
	MBX's Profitability Ratios	MBX's Asset Turnover Ratio	MBX's Dividend Growth
MBX's Roe	MBX's Valuation Ratios	MBX's Financial Strength Ratios	MBX's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-08T01:20:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.